(Q40330608)

English

P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors

scientific article published on February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

based on heuristic

inferred from title

author name string

Gianluca Brusa

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Elisa Zuffa

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Manuela Mancini

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Michela Benvenuti

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Natalia Calonghi

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Enza Barbieri

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Maria Alessandra Santucci

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

132

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

359-369

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Specific contributions of histone tails and their acetylation to the mechanical stability of nucleosomes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Expression of P21(WAF1/CIP1/SID1) cyclin-dependent kinase inhibitor in hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone deacetylase inhibition-mediated post-translational elevation of p27KIP1 protein levels is required for G1 arrest in fibroblasts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The Philadelphia translocation and pre-existing myeloproliferative disorders.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Genomic characterization reveals a simple histone H4 acetylation code.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Global regulation of post-translational modifications on core histones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Protein kinase CK2alpha is a target for the Abl and Bcr-Abl tyrosine kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

MLL: a histone methyltransferase disrupted in leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Mapping global histone acetylation patterns to gene expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Ectopic expression of protein-tyrosine kinase Bcr-Abl suppresses tumor necrosis factor (TNF)-induced NF-kappa B activation and IkappaBalpha phosphorylation. Relationship with down-regulation of TNF receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Structural basis for the autoinhibition of c-Abl tyrosine kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

TRRAP-dependent and TRRAP-independent transcriptional activation by Myc family oncoproteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Chronic myelogenous leukemia molecular signature.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histones and histone modifications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygeldanamycin synergistically induces apoptosis in Bcr-Abl+ Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, a

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Autoinhibition of Bcr-Abl through its SH3 domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The language of covalent histone modifications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Using chromatin immunoprecipitation to monitor 1alpha,25-dihydroxyvitamin D3-dependent chromatin activity on the human CYP24 promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Jak2 is involved in c-Myc induction by Bcr-Abl

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Induction of Apoptosis in BCR/ABL+ Cells By Histone Deacetylase Inhibitors Involves Reciprocal Effects on the RAF/MEK/ERK and JNK Pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Establishment of transcriptional competence in early and late S phase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Unique organization of the human BCR gene promoter

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The nucleosome core all wrapped up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05873.X

21 January 2018

The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1124/MOL.105.017145

Identifiers

10.1111/J.1365-2141.2005.05873.X

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40330608&oldid=2041548587"